Ezaki Glico achieved sales of 85,277 million yen in the first quarter of fiscal year 2026 (as of December 2026), representing a 10.3% increase YoY, with operating profit rising to 3,697 million yen (+40.7%). Segments such as overseas operations and nutritional snacks are also performing well.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2206","jir_company_name":"Ezaki Glico Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-05-08","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/2206-20260508-02.pdf","jir_short_summary":"Ezaki Glico achieved sales of 85,277 million yen in the first quarter of fiscal year 2026 (as of December 2026), representing a 10.3% increase YoY, with operating profit rising to 3,697 million yen (+40.7%). Segments such as overseas operations and nutritional snacks are also performing well.","jir_summary":"### Performance Overview\n\n\n### Outlook and Impact on Shareholders\nEzaki Glico maintains its full-year earnings guidance without revision, continuing steady growth. Through increased share buyback and expanded overseas deployment, the company aims to enhance shareholder returns and corporate value. Dividend forecasts are also maintained, ensuring stable shareholder returns. Going forward, the company will focus on strengthening the health and food segment and expanding in overseas markets, aiming for sustainable growth.","jir_financial_highlights":"Net Sales: 85,277 million yen (YoY +10.3%)\nOperating Income: 3,697 million yen (YoY +40.7%)\nNet Income Attributable to Owners of Parent: 3,583 million yen (YoY +46.0%)","jir_category":"","jir_hashtags":"#EzakiGlico, #IRFinancialResults, #JapaneseStocks","jir_key_figures":"Net sales: 85,277 million yen (+10.3% YoY)\nOperating income: 3,697 million yen (+40.7% YoY)\nNet income attributable to owners of parent: 3,583 million yen (+46.0% YoY)","jir_meta_title":"[Ezaki Glico] Q1 Fiscal Year 2026 Earnings\uff5cSales of 85 billion yen (+10.3%)","jir_meta_description":"Ezaki Glico achieved sales of 85,277 million yen in the first quarter of fiscal year 2026 (+10.3% YoY), with strong performance in overseas operations and nutritional snacks. The company plans to continue steady growth.","jir_og_title":"[Ezaki Glico] Q1 Fiscal Year 2026 Earnings\uff5cSales of 85 billion yen (+10.3%)","jir_og_description":"Ezaki Glico's Q1 FY2026 financial results show sales of 85 billion yen, with substantial profit growth, supported by expanded overseas operations and health divisions. Future growth prospects are promising.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8032,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-45893","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n